Literature DB >> 9605397

Pattern of presentation of multiple sclerosis in Saudi Arabia: analysis based on clinical and paraclinical features.

A K Daif1, S Al-Rajeh, A Awada, M Al Bunyan, A Ogunniyi, M AbdulJabar, A R Al Tahan.   

Abstract

We studied 89 MS patients comprising 38 males and 51 females seen over a 10-year period. The hospital frequency was 25/100,000 patients. The diagnosis was mainly clinical and was supported by neuroimaging, cerebrospinal fluid analysis and neurophysiological tests. Sixty-five patients (73%) were Saudis and the peak age of onset was in the third decade. Fifty-two patients (58.4%) had clinically definite MS, 17 (19.1%) had laboratory-supported definite MS, 15 (16.9%) were clinically probable MS cases and the remaining 5 (5.6%) had laboratory-supported probable MS. The mean age at onset of Saudi patients (25.9 years) was lower than that of the non-Saudis (29.4 years; p < 0.001). Involvement of the pyramidal system was the commonest mode of presentation. The clinical course was relapsing-remitting in 60.7%, progressive-relapsing in 20.2% and primary progressive in 19.1%. The number of systems involved was significantly associated with the duration of disease (p < 0.001). The demographic features and the variability of clinical presentation of Saudi MS patients is similar to the results from neighbouring countries. Combination of clinical features and paraclinical tests is essential for accurate determination of extent of dissemination and for unmasking clinically silent lesions.

Entities:  

Mesh:

Year:  1998        PMID: 9605397     DOI: 10.1159/000007931

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  8 in total

1.  Multiple sclerosis in Jordan: A clinical and epidemiological study.

Authors:  Khalid El-Salem; Ehsan Al-Shimmery; Khalid Horany; Ali Al-Refai; Kefah Al-Hayk; Yousef Khader
Journal:  J Neurol       Date:  2006-04-28       Impact factor: 4.849

2.  Is serum vitamin D levels associated with disability in patients with newly diagnosed multiple sclerosis?

Authors:  Hamidreza Hatamian; Elham Bidabadi; Seyed Mohammad Seyed Saadat; Niloufar Seyed Saadat; Ehsan Kazemnezhad; Hamed Ramezani; Babak Bakhshayesh
Journal:  Iran J Neurol       Date:  2013

3.  Clinical Presentations and Phenotypic Spectrum of Multiple Sclerosis at a University Hospital in Saudi Arabia.

Authors:  Saima Nazish; Rizwana Shahid; Azra Zafar; Foziah Alshamrani; Abdullah Al Sulaiman; Majed Alabdali; Danah Aljaafari; Esraa Al Wabari; Fahd A Alkhamis
Journal:  J Clin Neurol       Date:  2018-07       Impact factor: 3.077

4.  Social Anxiety and Obsessive-Compulsive Disorder Are Common Among Persons With Multiple Sclerosis at King Abdulaziz Medical City, Riyadh.

Authors:  Ismail A Khatri; Sarah Aljwair; Hajar Alammar; Amjad Altariq; Nazish Masud; Yaser Al Malik; Suleiman Kojan
Journal:  Cureus       Date:  2021-02-28

5.  Effect of Seasonal Variation on Relapse Rate in Patients With Relapsing-Remitting Multiple Sclerosis in Saudi Arabia.

Authors:  Seraj Makkawi; Ammar Aljabri; Ghassan Bin Lajdam; Ammar Albakistani; Abdulrahman Aljohani; Suhail Labban; Razaz Felemban
Journal:  Front Neurol       Date:  2022-03-14       Impact factor: 4.003

Review 6.  Multiple sclerosis in the Arabian Gulf countries: a consensus statement.

Authors:  Saeed Bohlega; Jihad Inshasi; Abdel Rahman Al Tahan; Abu Bakr Madani; Hussien Qahtani; Peter Rieckmann
Journal:  J Neurol       Date:  2013-03-17       Impact factor: 4.849

Review 7.  An Overview of the Intrinsic Role of Citrullination in Autoimmune Disorders.

Authors:  Mohammed Alghamdi; Doaa Alasmari; Amjad Assiri; Ehab Mattar; Abdullah A Aljaddawi; Sana G Alattas; Elrashdy M Redwan
Journal:  J Immunol Res       Date:  2019-11-25       Impact factor: 4.818

8.  Risk Factors Associated with Multiple Sclerosis: A Case-Control Study in Damascus, Syria.

Authors:  Maher Taan; Farah Al Ahmad; Mohammad Karim Ercksousi; Ghassan Hamza
Journal:  Mult Scler Int       Date:  2021-06-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.